Yogi Shohei

写真a

Title

Assistant Professor
To the head of this page.▲

Current Affiliation Organization 【 display / non-display 】

  • Duty   University of the Ryukyus   Faculty of Medicine   Health Sciences   Assistant Professor  

To the head of this page.▲

University 【 display / non-display 】

  • 2019.04
    -
    2021.03

    University of the Ryukyus   The Graduate School of Medicine   Department of Infectious, Respiratory, and Digestive Medicine   Graduated

  • 2019.04
    -
    2021.03

    University of the Ryukyus   Graduate School of Medicine   Department of Infectious, Respiratory, and Digestive Medicine   Graduated

To the head of this page.▲

Academic degree 【 display / non-display 】

  • University of the Ryukyus -  Master(Medical Sciences)

To the head of this page.▲

External Career 【 display / non-display 】

  • 2018.04
    -
    2022.08

    University of the Ryukyus Hospital  

  • 2022.09
    　
    　

    University of the Ryukyus  

To the head of this page.▲

Affiliated academic organizations 【 display / non-display 】

  • 　
    　
    　
     

    The Japanese Society for Clinical Microbiology 

  • 　
    　
    　
     

    Japanese Cancer Association 

  • 　
    　
    　
     

    The Japanese Association for Infection Diseases 

To the head of this page.▲

Research Interests 【 display / non-display 】

  • Morphological pathology

  • 感染症・薬剤耐性菌・形態学・病理学・発癌機序

  • Infection control

To the head of this page.▲

Research Areas 【 display / non-display 】

  • Kaposi's sarcom

  • Life Science / Tumor diagnostics and therapeutics

  • Cervical cancer

  • Antimicrobial-resistant bacteria

To the head of this page.▲

Acquisition of a qualification 【 display / non-display 】

  • Medical Technologist

To the head of this page.▲

Published Papers 【 display / non-display 】

  • Association between Kaposi's sarcoma-associated herpesvirus genotype and clinical types

    Yogi, S; Ishikawa, H; Oshiro, A; Yamazato, R; Sakamoto, C; Tanabe, Y; Uehara, K; Kurima, K; Kina, S; Takahashi, K; Arakawa, H; Kinjo, T

    PATHOLOGY & ONCOLOGY RESEARCH ( Pathology and Oncology Research )  31   1612009   2025.04 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

  • Detection of community-acquired respiratory viruses during COVID-19 pandemic in subtropical region in Japan

    Kami, W; Kinjo, T; Hashioka, H; Arakaki, W; Takahashi, A; Yogi, S; Uechi, K; Maeda, S; Yamamoto, K; Fujita, J

    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES ( European Journal of Clinical Microbiology and Infectious Diseases )  43 ( 12 ) 2269 - 2276   2024.12 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

    • Access this article
      DOI
    • Search related information
      PubMed

  • Evaluation of antimicrobial susceptibility testing method for colistin in Enterobacterales.

    The Japanese Society For Clinical Microbiology   34 ( 3 )   2024.06 [ Peer Review Accepted ]

    Type of publication: Research paper (other science council materials etc.)

  • Evaluation of an antimicrobial susceptibility testing system for <i>Aerococcus urinae</i> using DPS192iX

    SHIMOJI Maria, UECHI Kohei, NAKANO Ami, YOGI Shohei, UECHI Ayumi, MAEDA Shiro

    Japanese Journal of Medical Technology ( Japanese Association of Medical Technologists )  72 ( 4 ) 557 - 561   2023.10 [ Peer Review Accepted ]

    Type of publication: Research paper (other science council materials etc.)

    　View Summary

    <p>In this study, we evaluated the clinical usefulness of an automated antimicrobial susceptibility testing system (DPS192iX, Eiken Chemical Co. Ltd.) for <i>Aerococcus urinae</i>. MICs for nine antimicrobial agents, whose breakpoints were defined in CLSI M45 3rd Edition, were measured using DPS192iX for 38 <i>A. urinae</i> strains isolated and stored in the University of the Ryukyus Hospital between 2014 and 2020 and two ATCC strains, <i>Streptococcus pneumoniae</i> ATCC49619 and <i>A. urinae</i> ATCC51268. Results were compared with MICs determined by a reference method using frozen plates (Eiken Chemical Co., Ltd.). Overall, the ±1 essential agreement (±1 EA) and category agreement (CA) were 94.3% and 97.1%, respectively, whereas the ±1 EA or CA for several agents was less than 90% (±1 EA for ceftriaxone was 85.7%, that for linezolid was 88.6%, and CA for levofloxacin was 85.7%). The minor errors for ciprofloxacin and levofloxacin were 8.6% and 14.3%, respectively, but we did not observe a major error or a very major error. From these observations, the antimicrobial susceptibility testing system DPS192iX is considered useful for <i>A. urinae</i>, although further evaluation is required for several antimicrobial agents such as fluoroquinolones, ceftriaxone, and linezolid.</p>

  • Evaluation of the feasibility of EUCAST RAST using antimicrobial disks available in Japan.

    Uechi A, Uechi K, Nakano A, Yogi S, Shimoji M, Maeda S

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy ( Journal of Infection and Chemotherapy )  29 ( 10 ) 978 - 984   2023.10 [ Peer Review Accepted ]

    Type of publication: Research paper (scientific journal)

    • Access this article
      DOI
    • Search related information
      PubMed

display all >>

To the head of this page.▲